Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational Study
JMIR Research Protocols · 2025
DOI: 10.2196/71955 ↗At a glance
Studienprotokoll in JMIR Research Protocols, 2025. Written by Audrey Hoyt and 22 co-authors. Institution: University of Rochester Medical Center, Rochester, United States. Major MEDLINE topics: Parkinson Disease, Accidental Falls, Cognitive Dysfunction. 76 references. The full text is freely available in PubMed Central. Funded by: NINDS NIH HHS.
Topics: Sturzprophylaxe
Abstract (original language)
Background
Falls and cognitive impairment are major sources of disability in Parkinson disease (PD). The ability to accurately identify individuals with PD at high risk for falls and cognitive impairment would provide an opportunity for intervention and potentially improve long-term outcomes. In a previous study, Assessing Telehealth Outcomes in Multiyear Extensions of Parkinson Disease Trials (AT-HOME PD), we remotely characterized participants with early PD who had participated in 1 of 2 PD clinical trials over 2 years of follow-up. These participants with advancing disease provide a unique opportunity to examine whether the capture of objective in-home measures via digital tools and bothersome symptoms via direct participant report improves the prediction of disease milestones.
Objective
Assessing Telehealth Outcomes in Multiyear Extensions of Parkinson Disease Trials–2 (AT-HOME PD2) aims to examine whether digital tools and remote participant reporting can improve the prediction of falls and cognitive impairment, quantify changes in physical activity over time, and explore the relationship between physical activity and clinical progression over time.
Methods
This is a decentralized observational study of up to 200 individuals with PD, with clinical and digital phenotyping for up to 3 years of follow-up. Participants are those who took part in the STEADY-PD III (NCT02168842), Study of Urate Elevation in Parkinson’s Disease, Phase 3 (SURE-PD3; NCT02642393), AT-HOME PD (NCT03538262), or PD GENEration (NCT04057794) studies. All participants complete 2 video visits per year, wear 2 wrist-worn sensors (Fitbit Charge 5 and ActiGraph CentrePoint Insight Watch) for 1 week each month, complete smartphone-based motor tasks (using the mPower 2.0 app) for 10 days each quarter, and complete online surveys (within the companion Fox Insight study) each quarter. Falls are assessed via a weekly automated telephone call. A cognitive diagnosis is determined by a consensus committee that considers scores on a global cognitive measure, detailed neuropsychological tests, a cognitive-related disability measure, and clinical information. Prediction models will be constructed, and prediction accuracy will be compared across the models.
Results
Recruitment for the study was initiated in September 2023. Enrollment is ongoing, with 142 participants enrolled as of January 2025. Within the cohort, the average age is 69.2 (SD 8.7) years; 85 (59.9%) participants are male, 137 (96.5%) are White, and 2 (1.4%) are Hispanic or Latino; and the average disease duration is 8.9 (SD 1.3) years.
Conclusions
AT-HOME PD2 is remotely clinically and digitally phenotyping participants with midstage PD to predict falls and cognitive impairment and to provide insights into long-term progression. International Registered Report Identifier (IRRID) DERR1-10.2196/71955
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- University of Rochester Medical Center, Rochester, United States.
- Parkinson's Foundation, New York, NY, United States.
- Michael J. Fox Foundation, New York, United States.
- Eli Lilly (United States), Indianapolis, United States.
- University of Cincinnati Medical Center, Cincinnati, United States.
- Massachusetts General Hospital, Boston, MA, United States.
ORCID profiles: Audrey Hoyt, Casey Dorney, Peggy Auinger, Kathryn Murphy, Michelle Porto, Katrina Schmier, Renee Wilson, James C Beck, Stephanie Benvengo, Kevin Biglan, E Ray Dorsey, Alberto J Espay, Eric A Macklin, Mariana Hg Monje, Dan Novak, David Oakes, Larsson Omberg, Michael A Schwarzschild, Solveig K Sieberts, Tanya Simuni, Caroline M Tanner, Daniel Weintraub, Ruth B Schneider
Funding
- NINDS NIH HHS
Cite
APA
Hoyt, A., Dorney, C., Auinger, P., Murphy, K., Porto, M., Schmier, K., Wilson, R., Beck, J. C., Benvengo, S., Biglan, K., Dorsey, E. R., Espay, A. J., Macklin, E. A., Monje, M. H., Novak, D., Oakes, D., Omberg, L., Schwarzschild, M. A., Sieberts, S. K., …, & Schneider, R. B. (2025). Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational Study. JMIR Research Protocols. https://doi.org/10.2196/71955
Vancouver
Hoyt A, Dorney C, Auinger P, Murphy K, Porto M, Schmier K, et al. Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational Study. JMIR Research Protocols. 2025. doi:10.2196/71955
BibTeX
@article{Hoyt2025,
author = {Hoyt, Audrey and Dorney, Casey and Auinger, Peggy and Murphy, Kathryn and Porto, Michelle and Schmier, Katrina and Wilson, Renee and Beck, James C and Benvengo, Stephanie and Biglan, Kevin and Dorsey, E Ray and Espay, Alberto J and Macklin, Eric A and Monje, Mariana Hg and Novak, Dan and Oakes, David and Omberg, Larsson and Schwarzschild, Michael A and Sieberts, Solveig K and Simuni, Tanya and Tanner, Caroline M and Weintraub, Daniel and Schneider, Ruth B},
title = {Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational Study},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/71955}
}
EUVIMED